Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Other Non-Current Liabilities (2016 - 2022)

vTv Therapeutics (VTVT) has disclosed Other Non-Current Liabilities for 9 consecutive years, with $770000.0 as the latest value for Q1 2022.

  • Quarterly Other Non-Current Liabilities rose 1440.0% to $770000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $770000.0 through Mar 2022, up 1440.0% year-over-year, with the annual reading at $1.3 million for FY2021, 2424.0% up from the prior year.
  • Other Non-Current Liabilities hit $770000.0 in Q1 2022 for vTv Therapeutics, down from $1.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.3 million in Q4 2021 to a low of $50000.0 in Q4 2020.
  • Historically, Other Non-Current Liabilities has averaged $276294.1 across 5 years, with a median of $258000.0 in 2018.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 80.77% in 2020 and later soared 2424.0% in 2021.
  • Year by year, Other Non-Current Liabilities stood at $260000.0 in 2018, then changed by 0.0% to $260000.0 in 2019, then tumbled by 80.77% to $50000.0 in 2020, then skyrocketed by 2424.0% to $1.3 million in 2021, then plummeted by 38.99% to $770000.0 in 2022.
  • Business Quant data shows Other Non-Current Liabilities for VTVT at $770000.0 in Q1 2022, $1.3 million in Q4 2021, and $50000.0 in Q3 2021.